The White House issued a press release on July 24, 2020 stating that President Trump had signed four Executive Orders to decrease prescription drug costs and increase access to life-saving medication among Americans. The signing of the Executive Orders adds to the President’s previous efforts to drive the cost of prescription drugs for Americans down, and to provide the highest quality of healthcare to Americans at the lowest cost.
According to the White House, “the first Order directs federally qualified health centers to pass along massive discounts on insulin and epinephrine received from drug companies to certain low-income Americans. The second Order will allow State plans for safe importation of certain drugs, authorize the re-importation of insulin products made in the United States, and create a pathway for widespread use of personal importation waives at authorized pharmacies in the United States.”
“The third Order will prohibit secret deals between drug manufacturers and pharmacy benefit manager middlemen, ensuring patients directly benefit from available discounts at the pharmacy counter. The fourth and final Order ensures that the United States pays the lowest price available in economically comparable countries for Medicare Part B drugs.”